Kanker lambung stadium 2 Dokter Terbaik di Israel - TOP-15 dokter

Prof. Merimsky memimpin Unit Onkologi Jaringan Lunak dan Tulang di Sourasky Medical Center, dengan pengalaman khusus selama puluhan tahun dalam kanker lambung.

• Associate Professor Onkologi di Universitas Tel-Aviv
• Menjalani pelatihan Fellowship di Institut Gustave Roussy di Paris
• Anggota Fakultas Sarkoma ESMO dan ASCO
• Mempublikasikan secara luas tentang hasil pengobatan kanker

Dr. Pelles Sharon adalah spesialis dalam bedah kanker lambung di Sourasky Medical Center (Ichilov), dengan keahlian dalam perawatan tingkat lanjut seperti HIPEC dan imunoterapi.

• Melakukan operasi kanker lambung yang kompleks termasuk prosedur Whipple
• Mempelopori Kemoterapi Intraperitoneal Hipertermik (HIPEC) untuk kasus-kasus agresif
• Menawarkan opsi imunoterapi seperti Keytruda untuk pengobatan yang ditargetkan
• Memimpin penelitian klinis tentang sikap pasien onkologi terhadap uji coba klinis

Beliau memimpin Pusat Pencegahan Kanker khusus di Sourasky Medical Center Tel Aviv, yang berfokus pada deteksi dini dan pengobatan kanker gastrointestinal.

• Lebih dari 30 tahun pengalaman khusus dalam onkologi saluran gastrointestinal (GI)
• Kepala Pusat Pencegahan Kanker Terpadu – salah satu fasilitas kanker terkemuka di Israel
• Penulis lebih dari 300 makalah penelitian tentang pencegahan kanker dan terapi gen
• Menyelesaikan pekerjaan penelitian yang signifikan di NewYork-Presbyterian Center di AS
• Anggota masyarakat internasional utama seperti European Society of Digestive Oncology

Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.

He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.

He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.

Memimpin Inisiatif Kedokteran Genomik Nasional Israel – Dr. Raphael berspesialisasi dalam profil genomik tingkat lanjut untuk pengobatan kanker lambung yang dipersonalisasi di Sourasky Medical Center.

• Dosen Senior di Onkologi Medis dengan kepemimpinan uji klinis yang luas
• Ahli dalam biopsi cair dan profil genomik komprehensif
• Peneliti Utama (PI) untuk berbagai studi imunoterapi dan kemoterapi inovatif
• Anggota ESMO, IASLC, dan kelompok onkologi bergengsi lainnya
• Penerima berbagai penghargaan keunggulan dalam pengajaran dan penelitian

Dr. Wolf memimpin Divisi Onkologi Medis di Sourasky Medical Center – sebuah rumah sakit pendidikan utama di Israel dengan keahlian tinggi dalam perawatan kanker yang kompleks.

• Spesialisasi dalam onkologi medis dan penyakit dalam
• Fasih berbahasa Inggris untuk pasien internasional
• Memiliki gelar dari Universitas Ben Gurion
• Memperoleh pengalaman klinis yang luas di Unit Medis Angkatan Darat

Kepala Departemen Bedah Kolorektal di Sourasky Medical Center dan merupakan spesialis terkemuka dalam prosedur abdominal yang kompleks.

• Pengalaman bedah lebih dari 20 tahun
• Ahli dalam bedah terbuka maupun invasif minimal
• Spesialisasi dalam teknik tingkat lanjut seperti prosedur Whipple

Dr. Stepfansky memimpin unit rawat inap onkologi di rumah sakit terkemuka di Tel Aviv, Ichilov, dan berpartisipasi dalam uji klinis untuk perawatan terbaru.

• Lebih dari 20 tahun pengalaman dalam kedokteran internal dan onkologi
• Mengelola perawatan kanker rawat inap di Sourasky Medical Center
• Peneliti utama untuk studi klinis fase 1-3
• Menyelesaikan pelatihan ekstensif di Rumah Sakit Ichilov di Tel Aviv

Professional Profile

Dr. Almog Ben-Yaacov is a highly experienced surgeon specializing in general and oncological surgery. He graduated with honors from Semmelweis University Medical School in 2006. Following graduation, he completed two years of training in cardiac surgery, after which he continued with six additional years of advanced training in general surgery.

He currently serves as a senior surgeon at Sheba Medical Center. His clinical focus includes cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (CRS + HIPEC), as well as the management of gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, Dr. Ben-Yaacov has performed over 200 HIPEC procedures.

Advanced Training

Dr. Ben-Yaacov has completed multiple specialized international training programs, including:

ESSO-certified HIPEC surgery course in Hamburg, Germany

Microwave liver ablation training in Reims, France

NanoKnife (irreversible electroporation) training at King’s College, London

In 2019, he further expanded his expertise through advanced surgical oncology training at Memorial Sloan Kettering Cancer Center, New York, USA.

Clinical Expertise & Procedures

Cytoreductive surgery with HIPEC

Resection of abdominal wall metastases

Minimally invasive and laparoscopic surgery

General and gastrointestinal surgery

Colorectal surgery

Laparoscopic cholecystectomy

Abdominal surgery

Surgical oncology

NanoKnife (irreversible electroporation)

Laparotomy

Current Position

Attending Surgeon, Department of General and Oncological Surgery (Surgery C)

Education & Surgical Training

MD (with honors), Semmelweis University Medical School, Hungary

Cardiothoracic Surgery Training, Sheba Medical Center

General Surgery Training, Montefiore Medical Center (Einstein Campus), New York, USA

General Surgery Training, Rabin Medical Center (Beilinson Campus), Israel

Board Certifications

General Surgery

Surgical Oncology

Selected Publications

Correlation Between Intraoperative and Pathological Findings in Patients Undergoing CRS and HIPEC

Berger Y, Jacoby H, Kaufmann MI, Ben-Yaacov A, et al.

Laparoscopic vs Open Hartmann’s Reversal: A Decade-Long Multicenter Retrospective Study

Horesh N, Lessing Y, Rudnicki Y, Ben-Yaacov A, et al.

Readmission Rates and Risk Factors Following CRS and HIPEC for Peritoneal Surface Malignancies

Dreznik Y, Hoffman A, Hamburger T, Ben-Yaacov A, et al.

Prof. Ido Nachmany heads the Second Surgical Department at Sheba Medical Center. He specializes in HPB and robotic surgery for diseases of the liver, pancreas, and bile ducts, and for gastrointestinal neuroendocrine tumors. He also performs adrenal, spleen, and stomach surgery. Forbes listed him among Israel’s top physicians.

He advances minimally invasive robotic and laparoscopic techniques. The aim is better precision and faster recovery.

Credentials: Senior Lecturer at Tel Aviv University. Member of ASTS and IHPBA. Completed HPB and abdominal transplant fellowships at the Thomas E. Starzl Transplantation Institute. Board certified in General Surgery (Israel), Abdominal Organ Transplantation (ASTS), and HPB Surgery (University of Pittsburgh). He has published in Cancer Research, the Journal of the American College of Surgeons, and the European Journal of Surgical Oncology.

Department:

Gastrointestinal Cancer Department

Specialties:

Internal Medicine, Medical Oncology, Cancer Epidemiology

Prof. Ben Boursi is a leading specialist in Internal Medicine, Medical Oncology, and Radiotherapy at Sheba Medical Center. He earned his medical degree with distinction (cum laude) from the School of Medicine at Tel Aviv University.

He completed his residency in Internal Medicine at Sourasky Medical Center in Tel Aviv, followed by advanced subspecialty training in Gastrointestinal Oncology and Cancer Epidemiology at the University of Pennsylvania, USA.

Academic and Research Appointments

Prof. Boursi holds an academic position within the Department of Epidemiology and Preventive Medicine at the School of Medicine, Tel Aviv University. In addition, he serves as an Associate Scholar at the Perelman School of Medicine, University of Pennsylvania.

Research and Scientific Contributions

Prof. Boursi’s research is centered on developing innovative therapeutic approaches in oncology, with a particular focus on the role of the microbiome in cancer development and treatment response.

He is internationally recognized as a leader in microbial modulation in cancer therapy and founded the ECOG-ACRIN Microbiome Working Group. His work has been published in leading scientific journals, including Science, and presented at major global oncology conferences, as well as featured in ASCO educational platforms and podcasts.

Alongside his research, Prof. Boursi is actively involved in academic teaching, delivering lectures on host–microbiome interactions at Tel Aviv University and Bar-Ilan University.

His research also extends to cancer prevention and early detection. He has developed predictive models for early diagnosis of colorectal and pancreatic cancers, which are currently undergoing clinical evaluation.

Clinical Expertise

Gastrointestinal oncology

Current Position

Physician, Gastrointestinal Cancer Department

Education and Training

B.Med.Sc (Summa cum laude), School of Medicine, Tel Aviv University

MD (Magna cum laude), School of Medicine, Tel Aviv University

Clinical and Research Fellowship in Gastrointestinal Oncology and Cancer Epidemiology, Perelman School of Medicine, University of Pennsylvania

Elective Training in Medical Oncology, MD Anderson Cancer Center

Elective Training in Medical Oncology, Mayo Clinic

Advanced Research Training, Weizmann Institute of Science

Board Certifications

Internal Medicine

Medical Oncology

Professional Memberships

Israeli Association of Clinical Oncology and Radiotherapy (ISCORT)

American Society for Cancer Research

Selected Publications

Immune-related adverse events as predictors of durable response to BRAF inhibitors in metastatic melanoma with BRAF V600 mutation

Ben-Betzalel G, Baruch EN, Boursi B, et al.

Re-evaluating the IDEA classification: Novel predictive and prognostic markers in stage III colon cancer

Margalit O, Mamtani R, Yang YX, Boursi B, et al.

Prognostic significance of carcinoembryonic antigen (CEA) levels in stage I–II colon cancer

Margalit O, Mamtani R, Yang YX, Boursi B, et al

Dr. Alexander Beny memimpin Layanan Keganasan Gastrointestinal di Rambam Medical Center, yang berspesialisasi dalam pengobatan kanker lambung.

• Ahli onkologi bersertifikat dengan pelatihan ekstensif dalam onkologi medis dan radiasi
• Direktur Layanan Keganasan Gastrointestinal di Rambam Medical Center
• Lancar berbahasa Inggris dan Ibrani untuk pasien internasional
• Menyelesaikan pelatihan khusus dalam teknik brakiterapi modern

Profesor Tamar Jablonski-Perec memimpin departemen onkologi di Pusat Medis Hadassah, dengan pelatihan di Sloan-Kettering Cancer Center di New York.

• Memimpin Institut Onkologi sejak 1994
• Spesialisasi dalam pengobatan kanker payudara
• Profesor di Departemen Onkologi Universitas Ibrani
• Anggota komunitas kanker internasional
• Penerima beasiswa Sekolah Kedokteran Hadassah